Research News
What's New!
- MS Ireland and UCD research published. Read more
- MS Ireland to fund new myelin research. Read more
- New Trials in the UK are to investigate whether stem cells can be used to treat MS. Read more
- European Medicines Agency’s Committee for Medicinal Products for Human Use issues positive opinion on marketing authorisation application for FAMPYRA. Read more
- Multiple Sclerosis Ireland and The University of Limerick announce a collaborative partnership to mark World MS Day. Read more
- Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU. Read more
- The makers of Fampyra, also known as Fampridine, received a setback in January when the European Medicines Agency (EMA) recommended that the drug not be granted marketing authorisation. Read more
- Fingolimod is set to become the first licensed tablet to treat relapsing remitting MS in Europe, as the European Medicines Agency (EMA) makes steps to approve it. Read more
- St. Vincent’s University Hospital, Dublin is conducting a study into 'Cognitive Functioning in MS', led by Consultant Neurologist, Professor Tubridy, St Vincent's University Hospital, Dublin. Learn more here
- Sun exposure and vitamin D levels may have a role in MS. An Australian study published in the issue of 'Neurology' provides additional evidence for a potential role for low levels of sunlight exposure and vitamin D as triggers for multiple sclerosis. Read more
- David Byrne, M.D. Neurology Dept, St. James is asking you to participate in an online survey on 'Service needs for patients on long term therapy'. Read more
December 2010: Irish Research Breakthrough. Research funded by MS Ireland sheds light on secondary progressive MS. Read more
Thursday, 23rd December Irish Times Article: 'New perspective promises potential MS breakthrough'
October 2010: Dr Mark Pickering, School of Biomolecular and Biomedical Science, Conway institute, UCD. CCSVI Update (.pdf, 769KB)
24th September 2010: FDA Approves Oral Therapy. Read more
10th September 2010: Fingolimod (Gilenya) approved in Russia. Read article from MS Trust
2nd September 2010: Studies Challenge CCSVI Theory. Read more
28th July 2010 - Mobility Loss Leads to Reduced Productivity and Earning for People Living with Multiple Sclerosis. New research investigating how mobility impairment affects the lives of those with multiple sclerosis (MS) has found a substantial impact on workplace productivity and earnings. Read more (.doc, 86KB)
_____________________________________________________________
Pringle Lecture: Professor Michael Hutchinson, Consultant Neurologist in St Vincent’s Hospital, Dublin, gave a lecture on current research in environmental factors in MS and new emerging therapies. View lecture now
_____________________________________________________________
Stem Cells
8th June 2010 - International Society of Stem Cell Research (ISSCR) launches website. Read more
13th May 2010 - RTE 1 Prime Time: Controversy over Stem Cell Treatments. View Now
_____________________________________________________________
CCSVI
12th June 2010 - The National MS Society and the MS Society of Canada have announced $2.4 million of funding for seven new projects looking at chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis (MS). Read more
24th May 2010 - MSIF Statement on CCSVI. Read more
14th April 2010 - View a recording of the Web forum "CCSVI and what it could mean to people living with MS" with Dr. Paolo Zamboni, Dr. Robert Zivadinov, Dr. Andrew Common and Dr. Aaron Miller. View now
CCSVI Online Lecture: A presentation from Professor Michael D. Dake, Department of Cardiothoriac Surgery, Stanford University School of Medicine, Falk Cardiovascular Reseach Centre. Read more
CSSVI: Latest News and Information. Read more
_____________________________________________________________
Getting the Balance Right
G.T.B.R. Findings 2009. Read more
G.T.B.R. Research underway and completed by University Limerick. Read more
_____________________________________________________________
Multiple Sclerosis International Federation
The Multiple Sclerosis International Federation produce a weekly newsletter 'Making Connections' this is a comprehensive research section.
Read more research news from MSIF
_____________________________________________________________
UK MS Society
Read more research news
Multiple Sclerosis Trust
Read more research news
_____________________________________________________________
National Multiple Sclerosis Society
Read more research news
_____________________________________________________________
MS Society of Canada
Read more research news
_____________________________________________________________
Past Research News
Disability Research on Social Participation. Read more
“Multiple Sclerosis was definitely a life-changing event for me”. Chronic Illness as a Transformative Experience. Thesis by Silke Hoppe. Read more
Epstein-Barr Virus Researchers find further evidence linking Epstein-Barr Virus, risk of MS. Read more
LDN Phase II Trail results published. Read more
MS Ireland Research: Solving the MS Puzzle
Oral Therapies
Ireland's First Brain Bank launched to aid Research. Read more
Your Generosity at Work. Read more
Desperately Seeking Tysabri
Neuropathic Pain
Smoking Fears for MS Patients
New Facial Pain Drug Eases Discomfort
Cladribine
Alemtuzumab: A potential new MS drug
Measures in the first year of therapy predict the response to interferon {beta} in MS
MR-elastography reveals degradation of tissue integrity in multiple sclerosis
Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
Cognitive deficits in multiple sclerosis patients with cerebellar symptoms
Stem Cell Research
MS Scientist Honoured by University College Dublin
Research Identifies New Genes Linked With MS
NUI Galway Lecturer Leads International MS Research Project
_____________________________________________________________
